for the Period Ended 30 April 2023
Profit and loss | |
Balance sheet | |
Additional notes | |
Balance sheet notes | |
Community Interest Report |
for the Period Ended
2023 | 2022 | |
---|---|---|
| £ | £ |
Turnover: | | |
Cost of sales: | ( | ( |
Gross profit(or loss): | | ( |
Administrative expenses: | ( | ( |
Operating profit(or loss): | | ( |
Profit(or loss) before tax: | | ( |
Tax: | ( | |
Profit(or loss) for the financial year: | | ( |
As at
Notes | 2023 | 2022 | |
---|---|---|---|
| £ | £ | |
Current assets | |||
Cash at bank and in hand: | | | |
Total current assets: | | | |
Creditors: amounts falling due within one year: | 3 | ( | |
Net current assets (liabilities): | | | |
Total assets less current liabilities: | | | |
Creditors: amounts falling due after more than one year: | 4 | ( | |
Total net assets (liabilities): | | ( | |
Members' funds | |||
Profit and loss account: | | ( | |
Total members' funds: | | ( |
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 30 April 2023
Basis of measurement and preparation
for the Period Ended 30 April 2023
2023 | 2022 | |
---|---|---|
Average number of employees during the period | | |
for the Period Ended 30 April 2023
2023 | ||
---|---|---|
£ | ||
Taxation and social security | | |
Total | |
for the Period Ended 30 April 2023
2022 | ||
---|---|---|
£ | ||
Other creditors | | |
Total | |
The company has offered information for members of the public and introductory training to herbalists interested in Endobiogenic Medicine. The company is a small community interest company and thus does not require a social audit report. For the year ending 30/04/2021, the company was entitled to exemptions from audit under section 477 of the companies Act, 2006.
No consultation with stakeholders
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
30 January 2024
And signed on behalf of the board by:
Name: ANNE BETZ
Status: Director